Terminology Service for NFDI4Health
All terms in BAO
| Label | Id | Description |
|---|---|---|
| pediatric fibrosarcoma | DOID_3520 | |
| residence time | BAO_0001259 | |
| Kinactivation | BAO_0001258 | |
| axon fasciculation | BAO_0080010 | |
| fragments per kilobase of exon per million mapped reads | BAO_0080011 | |
| HEL cell | CLO_0003679 | |
| NF-KappaB p65 translocation | BAO_0080012 | |
| percent neurite outgrowth | BAO_0080013 | |
| percent neurite count | BAO_0080014 | |
| multiple endocrine neoplasia type 1 | DOID_10017 | [An autosomal dominant disease that has_material_basis_in a mutation in the MEN1 tumor suppressor gene and is characterized by over active endocrine glands frequently involving tumors of the parathyroid glands, the pituitary gland, and the pancreas.] |
| nephrocalcinosis | DOID_12679 | |
| calcinosis | DOID_182 | [A calcium metabolism disease that is the result of the formation of calcium deposits in any soft tissue.] |
| hypercalcemia | DOID_12678 | |
| calcium metabolism disease | DOID_10575 | |
| thyroid lymphoma | DOID_10011 | |
| thyroid cancer | DOID_1781 | [An endocrine gland cancer located_in the thryoid gland located in the neck below the thyroid cartilage.] |
| EC 1.10.3.2 (laccase) inhibitor | CHEBI_85050 | |
| EC 1.13.11.24 (quercetin 2,3-dioxygenase) inhibitor | CHEBI_85051 | |
| IC75 | BAO_0001265 | |
| EC25 | BAO_0001264 |